The main drugs currently used for treatment of visceral leishmaniasis.

aActual costs of the drugs, costs related to the logistics of storage and distribution are not taken into consideration.
bDue to long half-life + low genetic barrier (resistance readily obtained in lab isolates).
iv: intravenous; im: intramuscular.